Erica Drugs Private Limited - Company Profile

It is a trading private limited company based in Kolkata, West Bengal, India, established in 2019.
2019 Kolkata, West Bengal, India Active
Last Updated:
Access Report
About Erica Drugs Private Limited

Erica Drugs Private Limited, a active private limited company, was established on 18 November 2019 in Kolkata, West Bengal, India. Engaging in specialty within the trading sector, it holds CIN: U51909WB2019PTC234795. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹3.50 M and a paid-up capital of ₹2.75 M.

Its leadership includes Chhayarani Samanta (Director), Kajal Kumar Samanta (Director), Ruma Mukherjee (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 2Q, Bediadanga 2Nd Lane, Tiljala, Kolkata, West Bengal, 700039.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909WB2019PTC234795

  • Registration Number

    234795

  • Incorporation Date

    18 November 2019

  • Authorized Capital

    ₹3.50 M

  • Paid-Up Capital

    ₹2.75 M

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.50 M
  • Paid Up Capital ₹ 2.75 M
  • Company Age 6 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Erica Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Erica Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Erica Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Chhayarani Samanta Director 18 Nov 2019 Current
Kajal Kumar Samanta Director 18 Nov 2019 Current
Ruma Mukherjee Director 18 Nov 2019 Current
Shantanu Mukherjee Additional Director 30 Oct 2021 Current
Animesh Aich Additional Director 30 Oct 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Erica Drugs.

Enhance accessibility to Erica Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Erica Drugs revenue growth over time
Erica Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Erica Drugs?

Unlock access to Erica Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Erica Drugs?

Unlock and access historical data on people associated with Erica Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Erica Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Erica Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Erica Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Erica Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Erica Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata. was recorded as a recent event.

  • Director Appointment

    Shantanu Mukherjee was appointed as a Additional Director was appointed as a Additional Director on 30 Oct 2021 & has been associated with this company since 4 years 3 months . was recorded as a recent event.

  • Director Appointment

    Animesh Aich was appointed as a Additional Director was appointed as a Additional Director on 30 Oct 2021 & has been associated with this company since 4 years 3 months . was recorded as a recent event.

  • Director Appointment

    The activity Chhayarani Samanta was appointed as a Director was appointed as a Director on 18 Nov 2019 & has been associated with this company since 6 years 3 months . was completed.

  • Director Appointment

    Kajal Kumar Samanta was appointed as a Director was appointed as a Director on 18 Nov 2019 & has been associated with this company since 6 years 3 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Erica Drugs Private Limited?

The CIN of Erica Drugs Private Limited is U51909WB2019PTC234795.

Where is Erica Drugs Private Limited headquartered?

Erica Drugs Private Limited is headquartered at 2Q, Bediadanga 2Nd Lane, Tiljala, Kolkata, West Bengal, 700039.

When was Erica Drugs Private Limited incorporated?

Erica Drugs Private Limited was incorporated on 18 November 2019.

Who are the current directors of Erica Drugs Private Limited?

The current directors of Erica Drugs Private Limited are

What is the primary industry of Erica Drugs Private Limited?

The primary industry of Erica Drugs Private Limited is Trading.

Is Erica Drugs Private Limited a listed company?

Erica Drugs Private Limited is unlisted.

What is the capital structure of Erica Drugs Private Limited?

The authorized capital of Erica Drugs Private Limited is ₹3.50 M, and the paid-up capital is ₹2.75 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available